期刊文献+

老年COPD患者痰IL-4、IL-10、INF-γ水平及临床意义 被引量:8

Detection of sputum levels of IL-4,IL-10,INF-γ in elderly patients with COPD and its clinical implications
下载PDF
导出
摘要 目的探讨COPD患者痰白细胞介素4(interleukin,IL-4)、IL-10、干扰素-γ(interferon,INF-γ)水平及临床意义。方法老年COPD患者共60例(重度20例,中度20例,轻度20例),正常对照20例。采用双抗体夹心酶联免疫吸附实验,检测诱导痰IL-4、IL-10、INF-γ水平。结果①急性期重、中度COPD组痰IL-4水平低于轻度组(P<0.05)。②急性期重度组痰IL-10水平均高于轻度组。治疗后重度、中度组痰IL-10水平均比治疗前显著升高(P均<0.01)。③重、中度组急性期痰IFN-γ值显著高于治疗后缓解期(P均<0.01),且重、中度组急性期痰IFN-γ值均高于轻度组。④老年COPD患者痰中IL-4与IL-10;IL-10与IFN-γ存在相关,IL-4与IFN-γ不存在相关。结论 COPD时Th1类细胞因子(IFN-γ)呈优势状态;前炎症因子水平增高。 Objective To investigate the levels of IL-4, IL-10, and INF-γ in elderly patients with COPD and its clinical implica- tions. Methods 60 elderly patients with COPD, including 20 severe cases, 20 moderate cases and 20 mild cases, were recruited into the study. Besides, 20 healthy people were taken as the control group. The levels of IL-4, IL-10, and INF-γ were detected by sandwich ELISA. Results 1. The level of IL-4 was obviously lower in the severe and moderate patients than in the mild patients ( P 〈 0. 05 ). 2. The level of IL-10 was obviously higher in the severe group than in the mild group, and it increased obviously after the treatment in the se- vere and moderate patients ( P 〈 0.01 ). 3. The level of INF-γ were significantly higher in the severe and moderate patients than in the re- mission period after the treatment. 4. The level of IL-10 was correlated with the levels of IL-4 and INF-γ ( P 〈 0. 05 ), but there was no relationship between IL-4 and INF-γ. Conclusion The levels of INF-γ, IL-4, and IL-10 in sputum during the treatment can reflect the changes of inflammatory conditions in the airways of COPD patients.
出处 《临床肺科杂志》 2013年第6期1004-1006,共3页 Journal of Clinical Pulmonary Medicine
关键词 肺疾病 阻塞性 白介素-4 白介素-10 干扰素-Γ pulmonary disease obstructive Interleukin-4 Interleukin-10 Interferon-γ
  • 相关文献

参考文献9

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 2Chung KF. Cytokine as targets in chronic obstructive pulmonary dis-ease[ J]. Curr Drug Targets,2006,7 :675 -681. 被引量:1
  • 3Barnes PJ. Cytokine modulators as novel therapies for airway disease[J]. Eur Respir J Suppl,2001,34:67s-77s. 被引量:1
  • 4张建全,钟小宁,柳广南,李超乾.白细胞介素-10在慢性阻塞性肺疾病中作用探讨[J].广西医科大学学报,2008,25(1):30-31. 被引量:11
  • 5Zhu J, Qiu Y, Valobra M,et al. Plasma cells and IL-4 in chronicbronchitis and chronic obstructive pulmonary disease[ J]. Am J Re-spir Crit Care Med,2007 ,175 (1] ) : 1125 - 33. 被引量:1
  • 6Folli C,Chiappori A, Pellegrini M,et al. COPD treatment; real lifeand experimental effects on peripheral NK cells, their receptors ex-pression and their IFN--y secretion [ J ]. Pulm Pharmacol Ther,2012,25(5) :371 -6. 被引量:1
  • 7Wang ZD, Zheng T,Zhu Z, et al. Interferon Induction of Pulmona-ry Emphysema in the Adult Murine Lung[ J ]. The Journal of Exper-imental Medicine, 2000, 192:1587 - 1600. 被引量:1
  • 8Zhu J, Swati M, Qiu YS, et al. Interleukin-4 and Interleukin-5Gene expression and inflammation in the mucus-secreting glands andsubepithelial tissue of smokers with chronic bronchitis[ J] Am J Re-spir Crit Care Med, 2001,164:2220 -2228. 被引量:1
  • 9Chung KF. Cytokine as targets in chronic obstructive pulmonary dis-ease [J] . Curr Drug Targets,2006 ,7 :675 -681. 被引量:1

二级参考文献15

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989. 被引量:1
  • 3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946. 被引量:1
  • 4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012. 被引量:1
  • 5冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,. 被引量:2
  • 6Baraldo S, Turato G, Badin C, et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD[J]. Thorax, 2004,59 (4) : 308-312. 被引量:1
  • 7中华医学会呼吸病学会.慢性阻塞性肺疾病诊治规范(草案).中华结核和呼吸杂志,2002,25(3):453-460. 被引量:1
  • 8Norker RE, Schoonbrood DF, Van De Graaf EA, et al. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease [J]. Int Arch Allergy Immunol, 1996,109(2) :183-191. 被引量:1
  • 9Chernoff AE, Granowitz EV, Shapiro L,et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses[J]. J Immunol,1995,154(5):5 492-5 499. 被引量:1
  • 10John M, Lim S, Seybold J, et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma[J]. Am J Respir Crit Care Med ,1998,157(1) :256-262. 被引量:1

共引文献8240

同被引文献99

引证文献8

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部